Singapore, 11/23/17—Private equity firm the Everstone Group’s Everlife platform has purchased Malaysia-based Chemopharm. Chemopharm distributes medical products and solutions, including lab equipment, to over four thousand customers in Singapore, Thailand, Indonesia, Vietnam and the Philippines. The firm represents more than 50 manufacturers. “I recognize the tremendous value that Chemopharm and its executive team bring to Everlife in what will be an exciting journey of scaling the platform in existing and new geographies and into new product segments,” commented Troy Bailey, who along with Dr. Amit Kakar, will lead Everlife. Chemopharm Founder and CEO C A Ooi will maintain his role, as well as Chemopharm leadership.

Chemopharm distributes lab equipment and systems as well as manufactures lab furniture, according to an Everstone spokesperson. Discussing how Everlife plans to grow its lab equipment business, the Everstone spokesperson said, “Everlife is building one of the largest platforms across the region with multiple other acquisitions and access to many principals who are keen to have access across the region.”